Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2002
06/13/2002WO2002024224A3 Use of replication-deficient poxvirus vector to boost cd4+ t cell immune response to antigen
06/13/2002WO2002020038A3 Method for down-regulating ige
06/13/2002WO2002017948A3 Control of crop pests and animal parasites through direct neuronal uptake
06/13/2002WO2002014469A3 Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
06/13/2002WO2002012339A3 Sequences for integrin alpha-8
06/13/2002WO2002008263A3 Modified virus having an altered tropism
06/13/2002WO2002007646A3 Artificial vascular grafts, and methods of producing and using same
06/13/2002WO2002004495A3 Streptococcus pyogenes antigen
06/13/2002WO2002000173A3 Methods for use of delivery composition for expanding, activating, committing or mobilizing one or more pluripotent, self-renewing and committed stem cells
06/13/2002WO2001096377A3 Vaccine for congenital tremors in pigs
06/13/2002WO2001094547A3 Molecular delivery vehicle for delivery of selected compounds to targets
06/13/2002WO2001094415A3 Nuclear hormone receptor
06/13/2002WO2001092294A3 Therapeutic anti-melanoma compounds
06/13/2002WO2001091775A3 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity
06/13/2002WO2001090188A3 Receptor-based interaction trap
06/13/2002WO2001090159A3 Compositions and methods for delivery of a molecule into a cell
06/13/2002WO2001087981A3 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
06/13/2002WO2001072277A3 Immunotherapeutic methods and compositions
06/13/2002WO2001071018A3 Secreting products from skin by adeno-associated virus (aav) gene transfer
06/13/2002WO2001068828A3 Compositions and methods for regulated protein expression in gut
06/13/2002WO2001064889A3 Tnf-alpha variants for the treatment of tnf-alpha related disorders
06/13/2002WO2001059103A3 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
06/13/2002WO2001057242A3 Methods of protein destabilization and uses thereof
06/13/2002WO2001044300A3 Brain specific binding members
06/13/2002WO2001042461A3 Apoptin-associating protein
06/13/2002WO2001040798A3 Methods of using randomized libraries of zinc finger proteins for the identification of gene function
06/13/2002WO2001029256A3 Cephalic pain susceptibility marker
06/13/2002WO2001010444A3 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate
06/13/2002WO2000077262A9 Synthetic ligation reassembly in directed evolution
06/13/2002WO2000037610A3 Expression of immunogenic hepatitis b surface antigens in transgenic plants
06/13/2002US20020073448 Matrix attachment regions
06/13/2002US20020073447 Acquired resistance genes and uses thereof
06/13/2002US20020073446 Genetically modified plants having modulated brassinosteroid signaling
06/13/2002US20020073445 Methods for stable transformation of plants
06/13/2002US20020073444 Translational regulatory elements
06/13/2002US20020073439 Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson's disease
06/13/2002US20020072596 Nucleotide sequences coding transrerrins; for use in the treatment of nervous system., blood abbd anemia, heme biosynthesis disorders
06/13/2002US20020072595 Nucleic acid for use in kits for detection of preferential bacterial infection
06/13/2002US20020072584 Forming three dimensional cross- linked structure of a biocompatible polymeric material; solvent extracting the polymeric material with an extraction solvent, the solvent being solvent which generates volumetric swelling
06/13/2002US20020072550 Biostable polyurethane products
06/13/2002US20020072497 Novel DNA and recombinant production of novel polypeptides
06/13/2002US20020072496 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/13/2002US20020072494 Angiogenesis inhibitor, K1-5 (protease-activated kringles 1-5) genetically engineered so it can be secreted from cells in which it is expressed; contains a secretory signal peptide and a pre-activation peptide derived from plasminogen
06/13/2002US20020072491 Homology to members of the myosin light chain kinase subfamily
06/13/2002US20020072488 Amino acid sequences of human transporter peptides and proteins that are related to the sugar transporter subfamily; identifying modulators of the transporter peptides
06/13/2002US20020072120 Helper viruses for the preparation of recombinant viral vectors
06/13/2002US20020072117 Human feeder cells that support proliferation of undifferentiated pluripotent stem cells
06/13/2002US20020072115 Pancreatic islet cell growth factors
06/13/2002US20020072107 Human osteoclast derived cathepsin
06/13/2002US20020072106 Peptides selected by homology and/or structural relatedness to known protease proteins of the choriolytic hatching protease subfamily and expression pattern observed
06/13/2002US20020072101 Novel human nucleic acid molecules and polypeptides encoding cation channels
06/13/2002US20020072092 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/13/2002US20020072088 Monitoring protein associations and activity; obtain cells, measuring expression of reporter genes, adjustment in expression indicates modulatory activity
06/13/2002US20020072080 Immunological materials and methods for detecting dihydropyrimidine dehydrogenase
06/13/2002US20020072077 Nucleotide sequences coding enzymatic polypeptide; for use in bone marrow therapy
06/13/2002US20020072074 Solid support for use as diagnostic tool in the analysis and separation of biopolymers
06/13/2002US20020072067 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/13/2002US20020072066 Human osteoporosis gene
06/13/2002US20020071842 CD1 fusion proteins, preferably multivalent fusion proteins that are present in multimeric form (e.g., by Protein A binding multiple CD1 fusion proteins); diagnosis, vaccines
06/13/2002US20020071824 Gene transfer to pancreatic b cells for prevention of islet dysfunction
06/13/2002DE10061334A1 Verwendung von aus embryonalen Stammzellen hergeleiteten Zellen zur Erhöhung der Transplantationstoleranz und zur Wiederherstellung zerstörten Gewebes Using derived from embryonic stem cells to increase transplant tolerance and restore damaged tissue
06/13/2002CA2767270A1 Phosphatase stress-related proteins and methods of use in plants
06/13/2002CA2716959A1 Glp-1 fusion proteins
06/13/2002CA2706364A1 Method for the prevention or reduction of haze in beverages
06/13/2002CA2678490A1 Isolated placental perfusate and placental cells isolated therefrom
06/13/2002CA2436732A1 Protein modification and maintenance molecules
06/13/2002CA2436728A1 Glucuronyl c5-epimerase, dna encoding the same and uses thereof
06/13/2002CA2431861A1 Method of detecting and treating tuberous sclerosis complex associated disorders
06/13/2002CA2431203A1 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
06/13/2002CA2431202A1 Human sprouty-4 polypeptide
06/13/2002CA2431193A1 Sequences upstream of the carp gene, vectors containing them and uses thereof
06/13/2002CA2430993A1 G-protein coupled receptors
06/13/2002CA2430989A1 Method of collecting placental stem cells
06/13/2002CA2430947A1 Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
06/13/2002CA2430893A1 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
06/13/2002CA2430771A1 Dehydrated antigen presenting cells usable for vaccination
06/13/2002CA2430716A1 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
06/13/2002CA2430712A1 Schizophrenia-related voltage-gated ion channel gene and protein
06/13/2002CA2430624A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/13/2002CA2430558A1 Proteins and nucleic acids encoding same
06/13/2002CA2430536A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/13/2002CA2430524A1 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
06/13/2002CA2430206A1 Screening method for identifying compounds that selectively induce interferon alpha
06/13/2002CA2430191A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/13/2002CA2429959A1 Adipocyte complement related protein zacrp3x2
06/13/2002CA2429641A1 Kinases and phosphatases
06/13/2002CA2429094A1 Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
06/13/2002CA2428390A1 Enzymes
06/13/2002CA2428382A1 Intestinal proteins
06/13/2002CA2428208A1 Lipid-associated molecules
06/13/2002CA2428097A1 Immunomodulatory protein derived from the yaba monkey tumor virus
06/13/2002CA2427820A1 Method of producing biospecific molecules by protein trans-splicing
06/13/2002CA2427615A1 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
06/13/2002CA2399576A1 Inducible highly productive raav packaging cell-lines
06/13/2002CA2364983A1 Nucleic acid molecules and polypeptides for catabolism of abscisic acid
06/12/2002EP1213356A2 Synthetic DNA sequence having enhanced insecticidal activity in maize
06/12/2002EP1213355A2 Tapetum-specific promoters from brassicaceae spp
06/12/2002EP1213351A2 Nucleic acid enzymes acquiring an activity for cleaving a target RNA by recognising another molecule
06/12/2002EP1213348A2 Parasite-derived resistance
06/12/2002EP1213300A1 Novel human androgen receptor variants